|Category:||Clinical Stage Company Presentation|
|Time:||16:45 – 17:00|
Swati AG believes in the bioeconomy model for sustainable production of high-value products to be utilized in pharmaceuticals and nutraceuticals. Pentosan Polysulfate is Swati AGs flagship plant-derived product that is proof of success of the bioeconomy model in a pharmaceutical environment. Swati is now setting up a manufacturing site in Europe for production of polysaccharides and other products of natural origin and is collaborating with partners sharing this ideology.